01-283
COG ANBL00B1: NEUROBLASTOMA BIOLOGY STUDIES more details
 Protocol
 Consent Form
|
|
| |
01-284
CCG D9902: A COG SOFT TISSUE SARCOMA DIAGNOSIS, BIOLOGY AND BANKING PROTOCOL more details
Protocol
Consent Form
|
|
| |
04-050
COG ABTR01B1: A CHILDREN'S ONCOLOGY GROUP PROTOCOL FOR COLLECTING AND BANKING PEDIATRIC RESEARCH SPECIMENS INCLUDING RARE PEDIATRIC TUMORS. more details
Protocol
Consent Form
|
|
| |
05-057
COG ACNS02B3: A CHILDREN'S ONCOLOGY GROUP PROTOCOL FOR COLLECTING AND BANKING PEDIATRIC BRAIN TUMOR RESEARCH SPECIMENS. more details
Protocol
Consent Form
|
|
| |
05-511
COG ANBL00P3; PHASE III RANDOMIZED TRIAL OF INTRAVENOUS GAMMAGLOBULIN THERAPY FOR PATIENTS WITH NEUROBLASTOMA ASSOCIATED OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME TREATED WITH CHEMOTHERAPY AND PREDNISONE. more details
Protocol
Consent Form
|
|
| |
06-040
COG ANHL04B1: RARE AND CUTANEOUS NON-HODGKIN LYMPHOMA REGISTRY. more details
Protocol
Consent Form
|
|
| |
06-181
COG AREN03B2: RENAL TUMORS CLASSIFICATION, BIOLOGY AND BANKING STUDY. more details
Protocol
Consent Form
|
|
| |
2007-239
COG AALL05B1: A Childrens Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens more details
Protocol
Consent Form
|
|
| |
2007-240
COG AHOD04B1: Banking in Hodgkin Disease more details
Protocol
Consent Form
|
|
| |
2007-445
COG AREN0532: TREATMENT FOR VERY LOW, LOW AND STANDARD RISK FAVORABLE HISTOLOGY WILMS TUMOR more details
Protocol
Consent Form
|
|
| |
2008-294
ACCRN07-Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN). more details
Protocol
Consent Form
|
|
| |
2008-325
COG AALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomized of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND #76431; NSC #617807) more details
Protocol
Consent Form
|
|
| |
2008-399
COG AEWS07B1:A COG Study for Collecting and Banking Ewing Sarcoma Specimens more details
Protocol
Consent Form
|
|
| |
2008-400
COG AOST06B1: A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens more details
Protocol
Consent Form
|
|
| |
2008-540
COG AREN0533: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilmd Tumors: A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2009-098
COG ALTE05N1: Umbrella Long-Term Follow-up Protocol more details
Protocol
Consent Form
|
|
| |
2009-215
COG AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies more details
Protocol
Consent Form
|
|
| |
2009-312
COG AALL07P1: A Phase II Pilot Trial of Bortezomib (PS-341, Velcade®, IND# 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) more details
Protocol
Consent Form
|
|
| |
2009-376
COG AAML08B1: Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome more details
Protocol
Consent Form
|
|
| |
Pro00000525
COG ANHL1131: Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma or Mature B-cell Leukemia: Evaluation of Rituximab Efficacy and Saftey in High Risk Patients. more details
Protocol
Consent Form
|
|
| |
2009-449
COG AREN0534: Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor: A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2010-318
COG ACNS0831: Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Epedymoma Ages 1 to 21 Years: A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2010-005
COG AHEP0731: Treatment of Children with All Stages of Hepatoblastoma: A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2010-144
COG ARST08P1: A Pilot Study to Evaluate Novel Agent Cixutumab (IMC-A12, Anti-IGF-IR Monoclonal Antibody, IND #100947, NSC # 742460) in Combination with Intensive Multi-Agent Interval Compressed Therapy for Patients with High-Risk Rhabdomyosarcoma more details
Protocol
Consent Form
|
|
| |
2010-469
COG AALL08B1: Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) more details
Protocol
Consent Form
|
|
| |
2010-470
COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL): A Goupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2010-315
Treatment of Adrenocortical Tumors with Surgery plus Lymph Node Dissection and Multiagent Chemotherapy more details
Protocol
Consent Form
|
|
| |
2011-014
COG ARST0921: A Randomized Phase II Trial of Bevacizumab (IND# 7921, Avastin) and Temsirolimus (IND# 61010, Torisel) in Combination with Intravenous Vinorelbine and Cyclophosphamide in Patients with Recurrent/Refractory Rhabdomyosarcoma more details
Protocol
Consent Form
|
|
| |
2009-373
COG ALTE07C1: Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer: A Groupwide Non-therapeutic Study. more details
Protocol
Consent Form
|
|
| |
2011-015
COG ACNS0822:Randomized Phase II/III Study of Vorinostat IND 71976 and Local Irradiation OR Temozolomide and Local Irradiation or Bevacizumab IND 7921 and Local Irradiation Followed by Maintenance more details
Protocol
Consent Form
|
|
| |
2011-276
COG ADVL0921: A Phase II Study of MLN8237 (IND# 102984), a Selective Aurora Kinase Inhibitor, in Pediatric Patients with Relapsed/Refractory Solid Tumors and Leukemias more details
Protocol
Consent Form
|
|
| |
2011-277
COG ACNS0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Then Average Risk Medulloblastoma/ PNET Patients more details
Protocol
Consent Form
|
|
| |
2011-211
COG AEWS1031: A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma: A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2011-206
COG ACNS0821: Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial: A Groupwide Phase II Study more details
Protocol
Consent Form
|
|
| |
2011-524
COG AALL1131: Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC #606869) in the Versy High Risk Stratum: A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
2011-454
COG ACCL0934: A Randomized Trial of Levifloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Groupwide Phase III Study more details
Protocol
Consent Form
|
|
| |
